Pheochromocytoma triggered by coronavirus disease 2019: a case report

Hoda Naghshineh; Amirhossein Hasanpour; Naghmeh Ziaei; Mahmoud Sadeghi; Neda Meftah

doi:10.1186/s13256-022-03378-8

Pheochromocytoma triggered by coronavirus disease 2019: a case report

J Med Case Rep. 2022 Jun 10;16(1):233. doi: 10.1186/s13256-022-03378-8.

Authors

Hoda Naghshineh¹, Amirhossein Hasanpour², Naghmeh Ziaei³, Mahmoud Sadeghi¹, Neda Meftah¹

Affiliations

¹ Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Ganjafroz Street, Babol, I. R. of Iran.
² Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
³ Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Ganjafroz Street, Babol, I. R. of Iran. [email protected].

Abstract

Background: Coronavirus disease 2019 is an infectious disease with many presentations, and many of its effects on the human body are still unknown. Pheochromocytoma is a neuroendocrine tumor that may occur sporadically or be a manifestation of a hereditary disease line multiple endocrine neoplasia type 2.

Case presentation: In this study, we report a case of an Iranian patient infected with coronavirus disease 2019, causing unusual presentations of pheochromocytoma, including myocarditis and cerebrovascular involvement.

Conclusions: We discovered a case of pheochromocytoma as an unusual presentation of COVID-19. In further investigations we also discovered thyroid medullary carcinoma and at the end MEN 2 syndrome was diagnosed. After proper treatment many symptoms were eliminated.

Keywords: COVID-19; Cardiomyopathy; Case report; Coronavirus disease; MEN-2 syndrome; Pheochromocytoma.

Publication types

Case Reports

MeSH terms

Adrenal Gland Neoplasms* / pathology
COVID-19*
Humans
Iran
Multiple Endocrine Neoplasia Type 2a* / diagnosis
Pheochromocytoma* / complications
Pheochromocytoma* / diagnosis
Pheochromocytoma* / pathology
Thyroid Neoplasms* / diagnosis